CHF medications: Difference between revisions
(Text replacement - "qd" to "QD") |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 60: | Line 60: | ||
*Isordil: 60-80 TID | *Isordil: 60-80 TID | ||
*[[Captopril]]: 100 TID start 12.5 | *[[Captopril]]: 100 TID start 12.5 | ||
*[[Lisinopril]]/[[enalapril]]: 10 | *[[Lisinopril]]/[[enalapril]]: 10 BID class II/III | ||
**20 | **20 BID class IV | ||
*[[Carvedilol]] 25 BID; 50 BID if >80kg | *[[Carvedilol]] 25 BID; 50 BID if >80kg | ||
*[[Digoxin]]: varies | *[[Digoxin]]: varies | ||
*[[Spironolactone]] 25-50 | *[[Spironolactone]] 25-50 QD | ||
*[[Enalapril]] 1.25mg IV | *[[Enalapril]] 1.25mg IV | ||
*[[Nitroglycerin]] (Initial dose 5-10ug/min, increased every 3-5 minute to dose range 10-200ug/min) | *[[Nitroglycerin]] (Initial dose 5-10ug/min, increased every 3-5 minute to dose range 10-200ug/min) | ||
Latest revision as of 10:17, 7 July 2017
| Agent | RA | RCW | SVR | BP | CO |
| Isordil 60 | - | - | (-) | - | -/+ |
| Hydralazine 100 | ~ | ~ | - | +/- | ++ |
| hy (MR/AI) | - | -- | ++ | -/+ | +/- |
| ACEI | - | - | - | +/- | + |
| Minoxidil | ~ | ~ | -- | +/- | ++ |
- Carvedilol: decreases mortality 67%
- Digoxin: decrease syx/hospitaliz
- Aldactone in Class IV decrease mortality
- Isordil: cor. VD; +BP if ischemia
- ISDN/HYDRA. decreased mortality in CHF
- ACEI GREAT mortality benefit
Target Doses
- Hydralazine: 100 TID start 25
- Isordil: 60-80 TID
- Captopril: 100 TID start 12.5
- Lisinopril/enalapril: 10 BID class II/III
- 20 BID class IV
- Carvedilol 25 BID; 50 BID if >80kg
- Digoxin: varies
- Spironolactone 25-50 QD
- Enalapril 1.25mg IV
- Nitroglycerin (Initial dose 5-10ug/min, increased every 3-5 minute to dose range 10-200ug/min)
- Nitroprusside (Initial dose 5-10ug/min, increased every 3-5 minute to dose range 5-400ug/min)
^Consider when need afterload reduction